S. Muramatsu et al., METABOLISM OF PRAVASTATIN SODIUM BY 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE, Biological & pharmaceutical bulletin, 20(11), 1997, pp. 1199-1203
When incubated with isolated rat hepatocytes, pravastatin sodium (PS)
yielded a small amount of a metabolite in addition to tao major metabo
lites that have already been reported. The previously uncharacterized
metabolite was found to be formed by at first being enzymatically dehy
drogenated to 6'-keto intermediate (R-104), followed by decomposition
to give the aromatized metabolite (R-195), through spontaneous deester
ification with accompanying aromatization. The PS-6'beta-hydroxydehydr
ogenase activity was localized in cytosolic fraction and required NADP
, preferentially over NAD, as a cofactor. The formation of R-195 by ra
t liver cytosol was strongly inhibited by indomethacin, 3 alpha-hydrox
ysteroids (but not 3 beta-isomers) and 3-ketosteroids. The results and
high substrate specificity of purified PS-6'beta-hydroxydehydrogenase
toward 3 alpha-hydroxysteroids suggested that the enzyme is identical
to 3 alpha-hydroxysteroid dehydrogenase.